139 related articles for article (PubMed ID: 27449631)
1. Towards better modelling of drug-loading in solid lipid nanoparticles: Molecular dynamics, docking experiments and Gaussian Processes machine learning.
Hathout RM; Metwally AA
Eur J Pharm Biopharm; 2016 Nov; 108():262-268. PubMed ID: 27449631
[TBL] [Abstract][Full Text] [Related]
2. Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery.
Metwally AA; Hathout RM
Mol Pharm; 2015 Aug; 12(8):2800-10. PubMed ID: 26107396
[TBL] [Abstract][Full Text] [Related]
3. Supervised Machine Learning Algorithms for Evaluation of Solid Lipid Nanoparticles and Particle Size.
Öztürk AA; Gündüz AB; Ozisik O
Comb Chem High Throughput Screen; 2018; 21(9):693-699. PubMed ID: 30569864
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, drug release and computational modelling studies of antibiotics loaded amorphous chitin nanoparticles.
Gayathri NK; Aparna V; Maya S; Biswas R; Jayakumar R; Mohan CG
Carbohydr Polym; 2017 Dec; 177():67-76. PubMed ID: 28962797
[TBL] [Abstract][Full Text] [Related]
5. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).
Heider M; Hause G; Mäder K
Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354
[TBL] [Abstract][Full Text] [Related]
6. Effects of Fatty Acids on the Interfacial and Solution Behavior of Mixed Lipidic Aggregates Called Solid Lipid Nanoparticles.
Karmakar G; Nahak P; Guha P; Roy B; Chettri P; Sapkota M; Koirala S; Misono T; Torigoe K; Ghosh S; Panda AK
J Oleo Sci; 2016; 65(5):419-30. PubMed ID: 27150334
[TBL] [Abstract][Full Text] [Related]
7. Selecting optimum protein nano-carriers for natural polyphenols using chemoinformatics tools.
Metwally AA; El-Ahmady SH; Hathout RM
Phytomedicine; 2016 Dec; 23(14):1764-1770. PubMed ID: 27912878
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
9. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
Helgason T; Awad TS; Kristbergsson K; Decker EA; McClements DJ; Weiss J
J Agric Food Chem; 2009 Sep; 57(17):8033-40. PubMed ID: 19691283
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
Kupetz E; Bunjes H
J Control Release; 2014 Sep; 189():54-64. PubMed ID: 24933601
[TBL] [Abstract][Full Text] [Related]
11. Chemical and structural investigation of lipid nanoparticles: drug-lipid interaction and molecular distribution.
Anantachaisilp S; Smith SM; Treetong A; Pratontep S; Puttipipatkhachorn S; Ruktanonchai UR
Nanotechnology; 2010 Mar; 21(12):125102. PubMed ID: 20182010
[TBL] [Abstract][Full Text] [Related]
12. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
[TBL] [Abstract][Full Text] [Related]
13. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier.
Charoenputtakhun P; Opanasopit P; Rojanarata T; Ngawhirunpat T
Pharm Dev Technol; 2014 Mar; 19(2):164-72. PubMed ID: 23356887
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles.
Noack A; Hause G; Mäder K
Int J Pharm; 2012 Feb; 423(2):440-51. PubMed ID: 22197758
[TBL] [Abstract][Full Text] [Related]
18. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
Dening TJ; Rao S; Thomas N; Prestidge CA
Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
[TBL] [Abstract][Full Text] [Related]
19. Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency.
Seetapan N; Bejrapha P; Srinuanchai W; Puttipipatkhachorn S; Ruktanonchai U
Drug Dev Ind Pharm; 2010 Sep; 36(9):1005-15. PubMed ID: 20184417
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
